These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Severe hypertriglyceridaemia in Type II diabetes: involvement of apoC-III Sst-I polymorphism, LPL mutations and apo E3 deficiency. Marçais C, Bernard S, Merlin M, Ulhmann M, Mestre B, Rochet-Mingret L, Revol A, Berthezene F, Moulin P. Diabetologia; 2000 Nov; 43(11):1346-52. PubMed ID: 11126401 [Abstract] [Full Text] [Related]
5. In vitro catabolism of human very low density lipoproteins: fate of apoproteins B and C. Catapano AL, Capurso A, Kinnunen PK. Artery; 1981 Dec; 9(2):87-95. PubMed ID: 7295047 [Abstract] [Full Text] [Related]
6. Genetic epistasis in the VLDL catabolic pathway is associated with deleterious variations on triglyceridemia in obese subjects. Brisson D, St-Pierre J, Santuré M, Hudson TJ, Després JP, Vohl MC, Gaudet D. Int J Obes (Lond); 2007 Aug; 31(8):1325-33. PubMed ID: 17342071 [Abstract] [Full Text] [Related]
7. Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E. Ebara T, Ramakrishnan R, Steiner G, Shachter NS. J Clin Invest; 1997 Jun 01; 99(11):2672-81. PubMed ID: 9169497 [Abstract] [Full Text] [Related]
8. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype. Dergunov AD, Novoselov AV, Visvikis S, Siest G, Yakushkin VV, Tsibulsky V. Biol Chem; 2005 May 01; 386(5):441-52. PubMed ID: 15927888 [Abstract] [Full Text] [Related]
9. No evidence for linkage between familial hypertriglyceridemia and apolipoprotein B, apolipoprotein C-III or lipoprotein lipase genes. Heliö T, Palotie A, Sane T, Tikkanen MJ, Kontula K. Hum Genet; 1994 Sep 01; 94(3):271-8. PubMed ID: 8076943 [Abstract] [Full Text] [Related]